Skip to content

Clinical evaluation study on the combination of Chinese and Western medicine therapy to promote the recovery of middle-aged and elderly patients with novel coronavirus pneumonia

Clinical evaluation study on the combination of Chinese and Western medicine therapy to promote the recovery of middle-aged and elderly patients with novel coronavirus pneumonia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300070755
Enrollment
Unknown
Registered
2023-04-23
Start date
2021-09-01
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia

Interventions

control group:freely moving
respiratory rehabilitation group:KOO breathing exercise+aerobic breathing exercise+Elastic band resistance training
Baduanjin combined with respiratory rehabilitation group:Baduanjin+KOO breathing exercise+aerobic breathing exercise+Elastic band resistance training

Sponsors

Northern Jiangsu People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Patients who meet the criteria for discharge from the Novel Coronavirus Pneumonia Treatment Protocol (8th Edition). (2) Age between 45 and 80 years. (3) Informed consent and volunteered to be tested. The process of obtaining informed consent should be in accordance with GCP regulations. (4) ADL score of 100.

Exclusion criteria

Exclusion criteria: (1) Patients who have not met the discharge criteria of the treatment protocol for novel coronavirus pneumonia. (2) Patients with a combination of severe primary cardiac, hepatic, renal, haematological or other conditions affecting their survival. (3) Patients with mental illness, cognitive limitations and disabilities as defined by law. (4) Women who are pregnant or breastfeeding. (5) ADL score <100.

Design outcomes

Primary

MeasureTime frame
pulmonary function;

Secondary

MeasureTime frame
6MWT;Muscle strength measurement;Respiratory muscle strength measuremen;Self-rating Anxiety Scale;Depression Self-Rating Scale;

Countries

China

Contacts

Public ContactXing Jin

Northern Jiangsu People's Hospital

yzjinxing@qq.com+86 18051062457

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026